glp-1 alzheimer's 2025 GLP-1R agonists protect against disease by rewiring energy regulation GLP-1 Weight-Loss Drugs Ride Health,

Our compounded medications are prepared from active pharmaceutical ingredients (APIs) purchased from FDA-registered suppliers, and are not unapproved substances. All of our pharmacists and certified technicians are licensed and strictly regulated by State Boards of Pharmacy, so you can feel good knowing that you and your pet are in good, certified hands

Liegl B, Bennett MW, Fletcher CD

In contrast, DIO mice in both groups switched from WD to LD each had significantly increased Proteobacteria relative abundance (represented solely by the genus Parasutterella ) compared to both the WD and the LD controls, suggesting that Proteobacteria relative abundance may be largely influenced by stress or the differences in net energy expenditure (or associated body weight changes) caused by the diet switch

What they found: Favorable safety profile , no serious adverse events at doses up to 100 g/kg Preliminary efficacy signals positive The program stopped before Phase 3 for unknown commercial reasons (the program passed through several sponsor rotations and no one ultimately carried it through) Why it matters: These are the only published clinical data in humans that we have